Alan Eastman

Professor at Economics, Indiana University of Pennsylvania9 Followers

An authority in the field of finance and economics, Dr. Alan Eastman serves as a Professor in the Department of Finance and Economics at Indiana University of Pennsylvania (IUP). With a distinguished career in academia, Dr. Eastman has contributed significantly to the understanding of economic theories and financial practices. His extensive knowledge and expertise have made him a respected figure among students and colleagues alike. Dr. Eastman's academic journey has been marked by a commitment to excellence in teaching and research. At IUP, he is known for his engaging lectures and his ability to make complex economic concepts accessible to students. His dedication to education is evident in his innovative teaching methods and his mentorship of aspiring economists and finance professionals. In addition to his teaching responsibilities, Dr. Eastman is actively involved in various academic committees and initiatives within the university. His contributions to the field extend beyond the classroom, as he frequently participates in conferences and collaborates with fellow scholars on research projects. Dr. Eastman's office is located in Eberly Room 322-K, where he is always eager to engage with students and colleagues to discuss the latest developments in finance and economics.

Research Interests

Economic theories financial practices academic committees innovative teaching methods

Publications

1 - Targeting Microenvironment-Mediated NFκb Activation With MLN4924, An Inhibitor Of The Nedd8-Activating Enzyme, In Chronic Lymphocytic Leukemia B Cells,Blood

Claire Godbersen , Alan Eastman , Jennifer R. Brown , Alexey V. Danilov ,

, 2875-2875, 2013-11-15

2 - Abstract 2993: Vinblastine induces very rapid apoptosis in chronic lymphocytic leukemia and mantle cell lymphoma,Cancer Research

Darcy J. P. Bates , Christopher Lowrey , Alan Eastman ,

, 2993-2993, 2010-04-01

3 - Abstract B20: Schedule-dependent activation of DNA helicases by Checkpoint Kinase 1 inhibition following dNTP depletion causes CDK2-independent replication catastrophe,Molecular Cancer Research

Nicholas JH Warren , Alan R. Eastman ,

, B20-B20, 2017-04-01

4 - Abstract 943: The critical role of CDK2 activation in determining the differential sensitivity of cell lines to Chk1 and Wee1 inhibitors,Cancer Research

Nandini Sakurikar , Ruth Thompson , Ryan Montano , Alan Eastman ,

, 943-943, 2015-08-01

5 - Abstract 4298: Targeting the DNA damage checkpoint kinase Chk1 induces multiple pathways of cytotoxicity,Cancer Research

Nicholas Warren , Jennifer Ditano , Alan Eastman ,

, 4298-4298, 2018-07-01

6 - Abstract 2973: Differential regulation of p21waf1 protein half-life by DNA damage and nutlin-3 in p53 wild-type tumors and its therapeutic potential,Cancer Research

Li-Ju Chang , Alan R. Eastman ,

, 2973-2973, 2011-04-01

7 - Abstract 1040: Most putative BH3 mimetics preferentially antagonize the anti-apoptotic protein MCL-1 rather than BCL-2,Cancer Research

Tina C. Albershardt , Alexandre A. Pletnev , Alan Eastman ,

, 1040-1040, 2010-04-01

8 - Abstract 2040: The Mre11 nuclease is critical for sensitivity of cells to Chk1 inhibition,Cancer Research

Ruth H. Thompson , Ryan E. Montano , Alan R. Eastman ,

, 2040-2040, 2012-04-01

9 - Abstract 4412: S1 and gossypol induce NOXA through increased reactive oxygen species or cytoplasmic calcium and sensitize to ABT-737.,Cancer Research

Ryan S. Soderquist , Darcy J. P. Bates , Alan Eastman ,

, 4412-4412, 2013-04-01

10 - Abstract 2138: Vinblastine acutely sensitizes hematopoietic cancers to Bcl-2 targeting drugs,Cancer Research

Darcy J.P Bates , Christopher Lowrey , Alan Eastman ,

, 2138-2138, 2011-04-01

11 - The cancer therapeutic potential of Chk1 inhibitors: how mechanistic studies impact on clinical trial design,British Journal of Clinical Pharmacology

Ruth Thompson , Alan Eastman ,

, 358-369, 2013-08-20

12 - Confounding off-target effects of BH3 mimetics at commonly used concentrations: MIM1, UMI-77, and A-1210477,Cell Death & Disease

David J. Mallick , Ryan S. Soderquist , Darcy Bates , Alan Eastman ,

, 2019-02-22

13 - Structural requirements of human DNase IIalpha for formation of the active enzyme: the role of the signal peptide, N-glycosylation, and disulphide bridging,Biochemical Journal

Kyle S. MacLEA , Ronald J. KRIESER , Alan EASTMAN ,

, 867-876, 2003-05-01

14 - Defective p53 signaling in p53 wild-type tumors attenuates p21waf1 induction and cyclin B repression rendering them sensitive to Chk1 inhibitors that abrogate DNA damage-induced S and G2 arrest,Molecular Cancer Therapeutics

Aime A. Levesque , Andrew A. Fanous , Alissa Poh , Alan Eastman ,

, 252-262, 2008-02-01

15 - Cell cycle checkpoints and their impact on anticancer therapeutic strategies,Journal of Cellular Biochemistry

, 223-231, 2003-11-04

16 - Lifetime Earnings, Mortality, And Social Security Benefits: Implications For Reform,Journal of Applied Business Research (JABR)

Alan D. Eastman , Kevin L. Eastman ,

, 2011-01-10

Share Alan's Profile